The inhibitor of TGF-β/Smad signal pathways may be a strategy for prophylactic treatment of pulmonary fibrosis progression [20], and its cooperation with the expression of hepatocyte growth factor in pulmonary capillaries reduced silicosis fibrosis [21]. The gene discussed is TGFB1; the disease is pulmonary fibrosis.